Abstract
Osteoporosis is a systemic skeletal disease associated with an increased risk of fracture and characterized by reduced bone mass and qualitative alterations in bone structure (in both macro- and micro-architecture). Cases of osteoporosis appearing after menopause (postmenopausal) or with advancing age (senile) are defined as primary. Juvenile osteoporosis is commonly used to indicate the forms of osteoporosis that are found in childhood and adolescence: These pathologies are mostly due to genetic mutations that can involve quantitative or qualitative alterations of the connective component of the bone (as in osteogenesis imperfecta) or an altered osteoblastic activity majorly affecting the trabecular bone. On the other hand, secondary osteoporosis can be caused by a large number of pathologies and drugs (Tables 1 and 2). Osteoporosis is not a disease affecting only women, indeed, about 20% of all hip fractures occur in males and the incidence of vertebral fractures is about half that of females. However, contrary to the prevalence, in affected males mortality and morbidity from vertebral and femoral fractures are higher than in affected females [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abrahamsen B, Van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review [Internet]. Osteoporos Int. 2009 [cited 2021 May 24];20:1633–1650. Available from: https://pubmed.ncbi.nlm.nih.gov/19421703/.
WHO. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser. 1994;1994(843):1–129.
Rossini M, Adami S, Bertoldo F, Diacinti D, Gatti D, Giannini S, et al. Linee guida per la diagnosi, la prevenzione ed il trattamento dell’osteoporosi. Reumatismo. 2016;68(1):1–42.
Pothuaud L, Carceller P, Hans D. Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture. Bone [Internet]. 2008 [cited 2021 May 26];42(4):775–87. Available from: https://pubmed.ncbi.nlm.nih.gov/18234577/.
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos [Internet] 2013 [cited 2021 May 24];8(1–2). Available from: https://pubmed.ncbi.nlm.nih.gov/24113837/.
Brunader R, Shelton DK. Radiologic bone assessment in the evaluation of osteoporosis [Internet], vol. 65, American Family Physician; 2002 [cited 2021 Apr 4]. Available from: www.aafp.org/afp.
Rossini M, Adami S, Bertoldo F, Diacinti D, Gatti D, Giannini S, et al. Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo. 2016;68(1):1–39.
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos [Internet]. 2013 [cited 2021 Apr 1];8(1–2). Available from: https://pubmed.ncbi.nlm.nih.gov/24113837/.
Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int [Internet]. 2014 [cited 2021 Apr 8];25(10):2359–81. Available from: https://pubmed.ncbi.nlm.nih.gov/25182228/.
Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, et al. Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. J Clin Endocrinol Metab [Internet] 2021 [cited 2021 May 24];106(1):264–281. Available from: https://pubmed.ncbi.nlm.nih.gov/33103722/.
Khundmiri SJ, Murray RD, Lederer E. PTH and vitamin D. Compr Physiol. 2016;6(2):561–601.
Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar RN, et al. NCCN task force report: bone health in cancer care [Internet]. J Natl Compr Cancer Netw. 2009 [cited 2021 Apr 22];7. Available from: https://pubmed.ncbi.nlm.nih.gov/19555589/.
McCloskey E, Paterson AH, Powles T, Kanis JA. Clodronate. Bone [Internet]. 2020 [cited 2021 Apr 8];143. Available from: https://pubmed.ncbi.nlm.nih.gov/33127577/.
Agnusdei D, Iori N. Raloxifene: results from the MORE study. J Musculoskelet Neuronal Interact [Internet]. 2000;1(2):127–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15758505.
Yavropoulou MP, Makras P, Anastasilakis AD. Bazedoxifene for the treatment of osteoporosis. Expert Opin Pharmacother [Internet]. 2019 [cited 2021 Apr 8];20(10):1201–10. Available from: https://www.tandfonline.com/doi/full/10.1080/14656566.2019.1615882.
Rossini M, Adami G, Adami S, Viapiana O, Gatti D. Safety issues and adverse reactions with osteoporosis management [Internet], vol. 15. Expert Opinion on Drug Safety. Taylor and Francis Ltd; 2016 [cited 2021 Apr 8]. p. 321–2. Available from: https://pubmed.ncbi.nlm.nih.gov/26699669/.
Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med [Internet]. 2016 [cited 2021 May 24];375(16):1532–43. Available from: https://pubmed.ncbi.nlm.nih.gov/27641143/.
Cosman F, Crittenden DB, Ferrari S, Khan A, Lane NE, Lippuner K, et al. FRAME study: the foundation effect of building bone with 1 year of romosozumab leads to continued lower fracture risk after transition to denosumab. J Bone Miner Res [Internet] 2018 [cited 2021 May 24];33(7):1219–1226. Available from: https://pubmed.ncbi.nlm.nih.gov/29573473/.
Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, et al. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis. N Engl J Med [Internet]. 2017 [cited 2021 May 24];377(15):1417–27. Available from: https://pubmed.ncbi.nlm.nih.gov/28892457/.
Chandra R V., Maingard J, Asadi H, Slater LA, Mazwi TL, Marcia S, et al. Vertebroplasty and kyphoplasty for osteoporotic vertebral fractures: what are the latest data? [Internet], vol. 39.American Journal of Neuroradiology; 2018 [cited 2021 Apr 10]. p. 798–806. Available from: https://pubmed.ncbi.nlm.nih.gov/29170272/.
Fuggle NR, Kassim Javaid M, Fujita M, Halbout P, Dawson-Hughes B, Rizzoli R, et al. Fracture risk assessment and how to implement a fracture liaison service. In: 2021 [cited 2021 May 26]. p. 241–56. Available from: https://pubmed.ncbi.nlm.nih.gov/33347219/.
Chadha M, Shingare A, Prasanth A, Chauhan P, Shah NF. Fracture liaison service: prevention by coordination [Internet], vol. 22. Ind J Endocrinol Metab. Wolters Kluwer Medknow Publications; 2018 [cited 2021 May 26]. p. 719–21. Available from: https://pubmed.ncbi.nlm.nih.gov/30766806/.
Greco EA, Migliaccio S, Marcocci C, et al. Therapeutic appropriateness in osteoporosis. Endocrinologist. 2017;18:153–8.
Management of osteoporosis in postmenopausal women: the 2021 position statement of the North American Menopause Society. Menopause. 2021;28(9):973–97.
Angın E, Erden Z, Can F. The effects of clinical pilates exercises on bone mineral density, physical performance and quality of life of women with postmenopausal osteoporosis. J Back Musculoskelet Rehabil. 2015;28(4):849–58.
Küçükçakır N, Altan L, Korkmaz N. Effects of Pilates exercises on pain, functional status and quality of life in women with postmenopausal osteoporosis. J Bodyw Mov Ther. 2013;17(2):204–11.
Reid DM. Prevention of osteoporosis after breast cancer. Maturitas. 2009;64(1):4–8. https://doi.org/10.1016/j.maturitas.2009.07.008. Epub 2009 Aug 25. PMID: 19709826.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Montini, M., Pagani, A.A.M., Sporeni, S., Longhi, E.V. (2023). Osteoporosis. In: Longhi, E.V. (eds) Managing Psychosexual Consequences in Chronic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-31307-3_30
Download citation
DOI: https://doi.org/10.1007/978-3-031-31307-3_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-31306-6
Online ISBN: 978-3-031-31307-3
eBook Packages: MedicineMedicine (R0)